Financial services companies are using AI to assist with many business processes, including underwriting decisions, consumer credit approval, servicing and collections, loss mitigation programs, customer interaction on websites and mobile apps via chatbots, and in detecting fraud. In this fourth episode, Stephen Piepgrass and colleagues Chris Willis and Michael Yaghi examine the use and impact of AI in the financial services industry. They discuss the potential risks financial services companies may face with increased reliance on AI, as well as the increased focus on AI by various regulators and state attorneys general.

Our panel also offers practical suggestions for financial services companies who want to develop or adopt machine learning models into their business processes.

In our final episode of this series, we will discuss the impact and use of AI in Background Screening.

AI continues to capture the headlines. One recent headline noted that ChatGPT passed the medical boards. In this third episode, Stephen Piepgrass and colleagues Michael Yaghi and Barry Boise discuss the potential risks health care companies may face with increased reliance on AI, as well as the increased focus on AI by various regulators and state attorneys general, particularly in the health care space.

Our panel also offers suggestions on how health care companies can engage with state regulators to discuss the issues, share their perspective on how AI could assist the health care industry, and create an ongoing dialogue with regulators to make sure that private industry and the government are working together.

In part four of this podcast series, we will look at the use and impact of AI in the financial services industry.

Artificial intelligence (AI) has captured the imagination and generated excitement with consumers and businesses, but at the same time, developments in AI have also raised public concerns and spawned regulation that sometimes threatens to outpace the technological innovation we are seeing. In this second in our series on AI, Stephen Piepgrass and colleagues Jim Koenig and Chris Willis discuss the background of AI, including the opportunities and associated risks it presents, as well as the emerging global best practices surrounding the collection, use, and sharing of data and its use in AI.

Our panel provides a top 10 list of best practices that companies should be considering if they're thinking about using AI or are already using AI in their business processes.

In part three of this series, we will take a deep dive into the use and impact of AI in the health care industry.

Join us for the first in a series of episodes covering artificial intelligence (AI). As technology continues to develop, more companies are using AI in their day-to-day business, and with increased use comes increased risk. In this episode, Stephen Piepgrass and colleagues Michael Yaghi and Trey Smith provide an overview of AI, including uses and risks, and the increased focus on AI by various regulators, including state attorneys general, federal agencies, and local governments.

Our panel also offers insights on the potential legal pitfalls that businesses using AI should understand, and what they can do to prevent significant liability exposure to regulators.

Part two of this podcast series will focus on the technology, opportunities, risks, and best practices associated with the use of AI.

In this second of a two-part series, Stephen Piepgrass continues his discussion with colleagues Bryan Haynes, Agustin Rodriguez and Nick Ramos about significant developments in the tobacco industry during the past year, and their predictions on what to expect in the months ahead.

Our panel discusses tobacco excise taxes; challenges to flavor bans; FDA's regulation of nicotine levels; potential bans on menthol cigarettes and flavored cigars; enforcement of the PACT Act; and the forecast for litigation in 2023.

The U.S. tobacco industry is subject to a variety of regulators at the federal and state level. In this first of a two-part series focused on significant regulatory developments in the tobacco industry, Stephen Piepgrass is joined by colleagues Bryan Haynes, Agustin Rodriguez and Nick Ramos to review what happened over the past year, and offer thoughts on what to expect in the months ahead.

Our panel discusses federal regulations including important developments at the FDA, such as leadership changes, the pre-market review process, and actions on non-tobacco nicotine products. They also touch on the premium cigar industry's challenge to FDA's warning label requirement; the tobacco industry's challenge to FDA's graphic cigarette warning label rule; and a court order that resolved the government's long-running civil racketeering lawsuit against the largest U.S. cigarette companies.

Be on the lookout for part two of the podcast series.

In this episode of Regulatory Oversight, Ashley Taylor welcomes Professor Paul Nolette from Marquette University to discuss the evolution of state attorneys general and how their roles in government have shifted over the years. Professor Nolette serves as the chair of Marquette's Political Science Department and focuses his teaching and research on the dynamics of contemporary American federalism and the interplay between law and politics. Professor Nolette wrote the book Federalism on Trial: State Attorneys General and National Policy Making in Contemporary America, which examines how state litigators have used lawsuits against large corporations and the federal government as a way to influence national policy.

Over time, we have seen the AG role shift from being a capstone to ones career to more of a steppingstone for politicians. With this change, we also have seen a change in how state AGs approach federal government, federal government regulatory policies, and statutory policies — ultimately impacting numerous industries over the years.

Additionally, Ashley and Professor Nolette discuss what attracted him to study state AGs and the major developments he has seen with multistate settlements throughout his career as a professor and through his involvement with the National Association of Attorney General.

In this episode of Regulatory Oversight, Stephen Piepgrass welcomes Regulatory Investigations, Strategy + Enforcement Partner Ryan Strasser and Williams & Jensen Partner Matt Hoekstra to discuss how law firms can work with firms like Matt's on behalf of clients during congressional inquiries with parallel AG investigations or consumer litigation.

Additionally, our attorneys and Matt explore how legislative and regulatory initiatives may change now that mid-term elections are over, as well as how federal agencies find ways to work with state AGs to effectively expand their regulatory authority to help advance their enforcement priorities.

In this episode of Regulatory Oversight, Stephen Piepgrass is joined by Nevada First Assistant Attorney General Kyle George and Regulatory Investigations, Strategy + Enforcement attorneys Ketan Bhirud and Michael Yaghi to discuss the use of separate litigation and settlement counsel for AG investigations. Kyle also discusses the unique nature of attorney general investigations as compared to traditional litigation, and the benefits of having deep, meaningful relationships among the AG offices. 

In this episode of Regulatory Oversight, Stephen Piepgrass welcomes Regulatory Investigations, Strategy + Enforcement Partner Amy Williams and Health Sciences Partner Asher Funk to discuss the similarities and differences between the federal False Claims Act and state false claims acts, as well as emerging trends in state false claims act enforcement.

Though many states enacted false claims acts decades ago, we now see more enforcement activity and unique legal theories advanced by attorneys general who rely on false claims acts. Our attorneys discuss this shift, the intersection of matters brought under the federal and state false claims acts, areas ripe for enforcement, how our listeners can proactively avoid being on the receiving end of a CID, and what to do if they are.